Skip to main content
Home

Oncologieportal

Main navigation

  • Oncologieportal
    • Borst
    • Endocrinologie
    • Gastro-Enterologie
    • Gynaecologie
    • Hematologie
    • Hoofd-Halsgebied
    • Huid
    • Long/Mesotheliomen
    • Neurologie
    • Pediatrie
    • Sarcoom
    • Urologie en Nefrologie
  • Medi-Access
background_placeholder
non-hodgkin

Articles about non-hodgkin

     
Kies meer
Biology of Blood and Marrow Transplantation
In Trending

The cost-effectiveness of axicabtagene ciloleucel as second-line thera...

Biology of Blood and Marrow Transplantation
In Trending

Pneumococcal conjugate vaccine does not induce humoral response when a...

In Trending

Diffuse large B?cell lymphoma of the Waldeyer’s ring: A U.S. Populatio...

Biology of Blood and Marrow Transplantation
In Trending

Patterns of Use, Outcomes, and Resource Utilization among Recipients o...

In Trending

Brentuxinmab vedotin, alone or combine with bendamustine in the treatm...

PMLiVE
In Trending

Roche’s Lunsumio granted Priority Review by FDA for people with relaps...

ScienceDaily: Cancer News
In Trending

Researchers seek to improve success of chimeric antigen receptor-T cel...

In Wetenschap

April 2022: Drug Pipeline Updates?

Trending

Er zijn @count nieuwe artikelen
Friday, August 12, 2022 - 12:16 - In Trending
The cost-effectiveness of axicabtagene ciloleucel as second-line therapy in patients with large B-cell lymphoma in the United States: An economic evaluation of the ZUMA-7 trial
Friday, August 12, 2022 - 12:16 - In Trending
Pneumococcal conjugate vaccine does not induce humoral response when administrated within the six months after CD19 CAR T cell therapy
Tuesday, August 9, 2022 - 17:16 - In Trending
Diffuse large B?cell lymphoma of the Waldeyer’s ring: A U.S. Population?based survival analysis
Friday, July 15, 2022 - 12:16 - In Trending
Patterns of Use, Outcomes, and Resource Utilization among Recipients of Commercial Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed/Refractory Aggressive B-cell Lymphomas
Friday, July 15, 2022 - 01:08 - In Trending
Brentuxinmab vedotin, alone or combine with bendamustine in the treatment of natural killer T cell lymphoma
Thursday, July 7, 2022 - 14:32 - In Trending
Roche’s Lunsumio granted Priority Review by FDA for people with relapsed or refractory follicular lymphoma
Friday, May 13, 2022 - 04:40 - In Trending
Researchers seek to improve success of chimeric antigen receptor-T cell therapy in non-Hodgkin lymphoma
Monday, May 9, 2022 - 21:32 - In Wetenschap
April 2022: Drug Pipeline Updates?

Pagination

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • ›› Next page
  • » Last page

Kies uw tags

gastric cancer
glioblastoom
myelofibrosis
urothelial cell carcinoma
mCRC
non-small cell lung carcinoma
colorectal liver metastases
skin cancer
eierstokkanker
cholangiocarcinoma

Medzine logo gekleurd

Word op de hoogte gehouden van de laatste ontwikkelingen binnen oncologie via MedZine. Het nieuws wordt samengesteld uit meer dan 4.700 wetenschappelijke journals, beroepsverenigingen en andere gezaghebbende websites.

Sitemap

  • Trending
  • Wetenschappelijk
  • Uw nieuws

Support

  • Contact
  • Privacyverklaring
  • Gebruik van cookies

Medix

FTO

CEFI

 CME Academy

FarmacoTherapie Online

Medi-Access